Insights On Outsourced Drug Development

  1. Rapid Automated Selection Of Mammalian Cell Colonies 3/17/2025

    Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.

  2. How Biocatalysts Address Process Development Issues 7/23/2026

    Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.

  3. Navigating Complexity: Tailored Analytical & Preclinical Services 2/26/2026

    Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.

  4. Unified Lab Software For Modern QC Workflows 8/17/2026

    Manage increasingly complex chromatography workflows with a scalable data system that supports secure data management, instrument control, analysis, reporting, and high-resolution characterization.

  5. A Study To Assess Organoid Size And Cell Count From 3D Image Analysis 4/4/2025

    Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.

  6. Thermofluor Screening For Injectable Protein Formulations 9/15/2025

    The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

  7. Beyond PMI: Solvents As A Key To Sustainable Process Design 7/17/2026

    Discover how data-driven solvent selection helps uncover sustainability opportunities, boost efficiency, and enable smarter process optimization decisions.

  8. Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody 3/24/2025

    Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

  9. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  10. Streamlining Early Drug Development: Efficient Synthesis Of Highly Potent Compounds 5/6/2026

    Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.